1024. Real-world Adherence and Persistence with Long-Acting Cabotegravir Plus Rilpivirine (CAB+RPV LA) Compared to Oral Antiretroviral Therapy (ART) Among People with HIV (PWH) in the US: The ABOVE Study

BACKGROUND: CAB+RPV LA is the only complete long-acting regimen for treatment of virologically suppressed PWH. Administered monthly or every 2 months by a healthcare provider, CAB+RPV LA may alleviate adherence challenges with daily oral therapy. The ABOVE study evaluated real-world adherence and pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Garris, Cindy, Desai, Raj, Chang, Rose, Clear, Louise, Chen, Zhuo, Liu, Daisy, DerSarkissian, Maral, Teichner, Paula, Overton, Edgar T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678104/
http://dx.doi.org/10.1093/ofid/ofad500.055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678104/
http://dx.doi.org/10.1093/ofid/ofad500.055

Ejemplares similares